National Council for Prescription Drug Programs
Non-profit to standardize the exchange of healthcare information to improve outcomes
Based in AZ
AI Overview
With $220K in lobbying spend across 9 quarterly filings, National Council for Prescription Drug Programs is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $100K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that National Council for Prescription Drug Programs disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues around electronic healthcare standards and interoperability
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.